Avantor, Inc. $AVTR is Broyhill Asset Management LLC’s 9th Largest Position

Broyhill Asset Management LLC cut its stake in Avantor, Inc. (NYSE:AVTR) by 22.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 283,884 shares of the company’s stock after selling 80,339 shares during the quarter. Avantor comprises approximately 3.1% of Broyhill Asset Management LLC’s investment portfolio, making the stock its 9th biggest position. Broyhill Asset Management LLC’s holdings in Avantor were worth $3,543,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Greenhaven Associates Inc. acquired a new position in Avantor in the 3rd quarter valued at about $228,528,000. Dodge & Cox lifted its holdings in Avantor by 17.1% in the second quarter. Dodge & Cox now owns 117,433,484 shares of the company’s stock valued at $1,580,655,000 after acquiring an additional 17,170,761 shares during the last quarter. Norges Bank purchased a new position in Avantor in the second quarter worth approximately $108,167,000. Engine Capital Management LP acquired a new stake in Avantor during the second quarter worth $74,088,000. Finally, Clarkston Capital Partners LLC increased its stake in Avantor by 45.8% during the second quarter. Clarkston Capital Partners LLC now owns 13,982,090 shares of the company’s stock worth $188,199,000 after acquiring an additional 4,390,140 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Avantor news, Director Sanjeev K. Mehra bought 125,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 10th. The shares were purchased at an average price of $8.01 per share, with a total value of $1,001,250.00. Following the completion of the acquisition, the director directly owned 475,000 shares of the company’s stock, valued at $3,804,750. This represents a 35.71% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gregory L. Summe acquired 100,000 shares of the stock in a transaction dated Thursday, February 12th. The shares were acquired at an average cost of $9.40 per share, with a total value of $940,000.00. Following the completion of the transaction, the director owned 400,000 shares in the company, valued at approximately $3,760,000. This represents a 33.33% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought 275,000 shares of company stock worth $2,399,250 in the last 90 days. Corporate insiders own 1.20% of the company’s stock.

Avantor Trading Up 0.5%

NYSE:AVTR opened at $7.94 on Friday. Avantor, Inc. has a 12-month low of $7.82 and a 12-month high of $17.11. The firm has a market cap of $5.41 billion, a PE ratio of -10.18, a price-to-earnings-growth ratio of 3.10 and a beta of 0.97. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.70. The stock has a fifty day moving average price of $10.36 and a 200 day moving average price of $11.69.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.01. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.The business had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the business posted $0.27 EPS. The business’s quarterly revenue was down 1.4% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Sell-side analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have commented on AVTR shares. Zacks Research downgraded Avantor from a “hold” rating to a “strong sell” rating in a research report on Friday, February 13th. Wells Fargo & Company cut their price objective on Avantor from $16.00 to $14.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Citigroup reduced their price objective on shares of Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a report on Thursday, February 12th. UBS Group reaffirmed a “neutral” rating and set a $10.50 target price on shares of Avantor in a research note on Thursday, February 12th. Finally, Stifel Nicolaus set a $10.00 price target on shares of Avantor in a research report on Thursday, February 12th. Three equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $11.80.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.